Literature DB >> 8520217

Sympathetic skin response in Guillain-Barré syndrome.

A B Taly1, G R Arunodaya, S Rao.   

Abstract

Dysautonomia is a common feature of Guillain-Barré (GB) syndrome and is sometimes the cause of significant morbidity and death. Changes in sympathetic skin response (SSR) may be one of the accompaniments of dysautonomia. An attempt was made to correlate SSR changes with clinical and electrophysiologic features in a group of 24 patients with GB syndrome fulfilling NINDS (National Institute of Neurological Disorders and Stroke) criteria. A total of nine patients had absent SSR. Thirteen patients had clinical dysautonomia, of whom five had absent SSR. Five patients had features of predominant axonal damage and preserved SSR. A trend towards correlation of SSR abnormalities with common peroneal nerve conduction parameters (velocity and compound muscle action potential amplitude) was noted. We conclude that SSR abnormalities are common in GB syndrome and may be complementary to bed-side tests for autonomic dysfunction.

Entities:  

Mesh:

Year:  1995        PMID: 8520217     DOI: 10.1007/BF01824010

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  9 in total

1.  Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.

Authors:  J W Albers; P D Donofrio; T K McGonagle
Journal:  Muscle Nerve       Date:  1985 Jul-Aug       Impact factor: 3.217

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Autonomic function and unmyelinated fibers in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  T J Ingall; J G McLeod; N Tamura
Journal:  Muscle Nerve       Date:  1990-01       Impact factor: 3.217

4.  Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.

Authors:  B T Shahani; J J Halperin; P Boulu; J Cohen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

5.  Autonomic dysfunction in Guillain-Barré syndrome.

Authors:  R R Tuck; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-11       Impact factor: 10.154

6.  RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy.

Authors:  B T Shahani; T J Day; D Cros; N Khalil; C S Kneebone
Journal:  Arch Neurol       Date:  1990-06

7.  Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation.

Authors:  S K Gupta; A B Taly; T G Suresh; S Rao; D Nagaraja
Journal:  Acta Neurol Scand       Date:  1994-03       Impact factor: 3.209

Review 8.  Autonomic involvement in Guillain-Barré syndrome: a review.

Authors:  D W Zochodne
Journal:  Muscle Nerve       Date:  1994-10       Impact factor: 3.217

9.  Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome.

Authors:  A H Ropper; E F Wijdicks; B T Shahani
Journal:  Arch Neurol       Date:  1990-08
  9 in total
  4 in total

1.  Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Authors:  Cheng-Yin Tan; Nortina Shahrizaila; Kee-Ying Yeoh; Khean-Jin Goh; Maw-Pin Tan
Journal:  Clin Auton Res       Date:  2018-04-13       Impact factor: 4.435

2.  Sympathetic skin response in myelopathies.

Authors:  K P Nair; A B Taly; G R Arunodaya; S Rao; T Murali
Journal:  Clin Auton Res       Date:  1998-08       Impact factor: 4.435

3.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

4.  The effect of stimulation technique on sympathetic skin responses in healthy subjects.

Authors:  Elisabeth Chroni; Andreas A Argyriou; Panagiotis Polychronopoulos; Vassiliki Sirrou
Journal:  Clin Auton Res       Date:  2006-11-01       Impact factor: 4.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.